Quick Answer: Functional cosmetics in South Korea are cosmetics within the legally defined functional scope, with the applicable MFDS examination or reporting route before marketing. First classify the finished product and its claims, then determine whether examination or a qualifying report applies and assemble evidence for that exact formula and use. Functional status is distinct from business registration and does not replace ingredient, quality, Korean labelling or advertising requirements.
Classify the purpose before choosing the submission route
Start with the definition of functional cosmetics in the current Korean Cosmetics Act and the scope specified by the applicable subordinate rules. The Act addresses areas including skin whitening, wrinkle improvement, tanning or ultraviolet protection, hair colour or certain hair functions, and specified skin or hair condition benefits. The detailed category wording and exclusions matter more than a loose marketing translation.
Examples help organise the review: a sunscreen proposition, a whitening claim and a wrinkle-improvement claim should trigger a Korean functional assessment. Products positioned around hair loss symptoms, certain acne-prone skin uses or other specified skin conditions need careful checking against the detailed scope. Do not infer that every hair-care or sensitive-skin product is functional, or that a cosmetic may make any disease-treatment claim.
Write a classification brief containing the proposed Korean name, complete claims, directions, use area, target users and final formula revision. Ask the reviewer to explain which category applies, which wording is outside the intended boundary and whether the presentation raises a different product category. Classification should be resolved before commissioning expensive evidence or printing the pack.
| Question | Ordinary cosmetic | Functional cosmetic |
|---|---|---|
| What defines the starting point? | Cosmetic purpose outside the functional scope | A purpose within the defined functional scope |
| What product pathway is considered? | Applicable ordinary cosmetic obligations | Applicable functional examination or report |
| Does the formula still need review? | Yes, for the actual ingredients and use | Yes, including relevant functional conditions |
| Do local business duties remain? | Yes | Yes |
| Can marketing expand claims freely? | No, claims need lawful support and review | No, stay within the supported product scope |
Understand examination and reporting as distinct pathways
The MFDS cosmetics process overview describes examination or reporting for functional cosmetics. The existence of a reporting option does not mean that every functional product can select it. Determine the applicable criteria, then compare them with the actual product rather than assuming that a familiar ingredient or an overseas supplier’s standard base is sufficient.
The Enforcement Rule framework for functional examination sets out the examination application structure and recognises the separate reporting route. A Korean reviewer should identify the relevant provisions and MFDS notices for the product. Where a reporting basis is claimed, retain a comparison that demonstrates the required product match and conditions. Where examination is needed, map the requested data against the applicable requirements and any permitted omissions.
Do not describe either pathway as a generic FDA approval. Identify the Korean authority, specific product, applicant or responsible party, route and record. Business registration, ingredient-list reporting and functional-product reporting are separate administrative matters. A clear tracker prevents a completed business task from being mistaken for completed functional product work.
Make the route worksheet specific enough to audit
Create one worksheet per product version. Record functional category, claimed benefit, relevant ingredients and amounts, dosage form, directions, manufacturing site and proposed Korean wording. Add the intended record holder and the exact basis for examination or reporting. Link each conclusion to an authority and an evidence file that another reviewer can locate.
For a purported match to an established reporting condition, check all relevant dimensions instead of comparing only the headline active ingredient. Formula, content, specifications, use and other conditions can matter under the applicable route. Escalate any difference with a precise explanation and obtain a conclusion before treating the report pathway as available.
If one product combines functions, do not assume evidence for one benefit covers the other. Map each intended function separately and ask how the combined product should be handled. The same discipline applies when changing a base formula or pack after evidence has been generated. A supplier’s internal product code helps traceability, but it does not determine regulatory equivalence.
| Evidence area | Question to resolve | Useful controlled record |
|---|---|---|
| Classification | Which defined function and claim applies? | Korean classification brief |
| Route eligibility | Examination or qualifying report? | Legal basis and product comparison |
| Composition and quality | What exact product is assessed? | Quantitative formula and specifications |
| Safety and efficacy | What data are required for this route? | Study matrix and relevant reports |
| Consumer wording | What benefit may be communicated? | Approved Korean claims and pack proof |
Use finished-product evidence for the question it actually answers
Ask the Korean reviewer to establish the safety, efficacy and quality data requirements for the chosen route before selecting laboratories. Some routes or conditions may allow particular data to be omitted; that needs a documented basis. Avoid ordering a generic bundle of tests and discovering later that the study design does not address the required endpoint.
A raw-material paper, supplier presentation and finished-product study answer different questions. Record whether a report concerns the actual marketed formula, a component or another formulation. Check sample identity, concentration, method, endpoint, protocol, population where relevant and the limits of the conclusion. Do not turn an ingredient observation into an unrestricted finished-product benefit claim.
For ultraviolet protection, agree the relevant performance measures and test basis for the intended claims with the reviewer. For other functions, define the exact benefit and accepted evidence approach. This guide does not prescribe universal numerical thresholds, study durations or guaranteed acceptance. Those details depend on the current rules and specific product route.
The OEM/ODM manufacturer can help supply composition, specifications, representative samples and available study reports. The brand should coordinate the claim brief and schedule, while the Korean operator and qualified reviewer resolve local requirements. This division of work supports the submission; it does not imply that a manufacturer automatically holds a Korean approval.
Control formula and manufacturing identity throughout the process
Freeze the assessed formula revision before finalising the evidence package. Include constituent information for premixes and blend ingredients so the reviewer can reproduce the finished composition. Keep raw-material identity, specification and supplier records linked to that revision. An English ingredient list alone is too limited for evaluating a functional product’s conditions.
Reconcile laboratory sample codes, production formula codes and final commercial SKU names. Where the names differ, retain a signed cross-reference explaining the relationship. Check that the tested packaging and product directions reflect the intended sale, or document the assessment of any difference. Small inconsistencies can make a technically strong file difficult to interpret.
Require change control for the formula, raw materials, manufacturing site, process and packaging. Ask whether the proposed change affects the existing route, record, data or claim support. Do not assume an earlier examination or report applies unchanged to a revised product. Resolve the impact before producing stock intended for the Korean market.
| Workstream | Manufacturer role | Brand and Korean operator role |
|---|---|---|
| Technical file | Supply accurate composition and product data | Assess route and coordinate local records |
| Performance studies | Supply representative samples and reports | Define claim, evidence need and acceptance basis |
| Korean pack | Confirm pack and coding specifications | Approve required particulars and wording |
| Imported batch | Provide traceable production and quality data | Apply local inspection and release controls |
| Product change | Notify differences before implementation | Review impact on route, evidence and stock |
Approve functional wording with the full Korean pack
The packaging particulars in Cosmetics Act Article 10 include the functional indication where applicable, alongside other required information. Review the detailed labelling rules, relevant qualifications and packaging exceptions for the actual product. Keep functional statements consistent with the assessed product and supported scope.
Review product names, icons, before-and-after imagery, directions and retailer descriptions together. A cautious pack can still be undermined by an online listing that implies treatment of a disease or promises a broader result than the evidence supports. Give agencies and resellers approved Korean wording and a process for submitting proposed changes.
Save the complete joined Korean text and final artwork proof, including the smallest size. Check readability and whether mandatory information remains visible after a sticker or packaging finish is applied. Link the approved artwork to the product route record and formula revision so the warehouse and sales team can identify the correct version.
Treat the functional record as one part of market readiness
A completed functional route does not remove responsible distribution, import quality or post-sale safety obligations. The responsible distributor duties in Rule Article 12 address imported records, batch controls and safety information. Agree the inspection arrangement, traceability system and release decision for each shipment with the Korean operator.
Our South Korean launch guide explains the broader operating sequence, while the regulatory framework guide separates business, product, technical and consumer-facing layers. Keep those workstreams visible in the same project plan. A functional record without a reconciled shipment file does not by itself answer whether a particular batch is ready for distribution.
Read effective dates carefully. The current Act version took effect on 20 October 2026, while the database includes later-effective provisions in November 2026 and 2027. Keep the present conclusion separate from future planning and recheck before a later launch. If technical coordination is needed, contact the project team with the exact product, function and unresolved evidence questions. Preserve complaint and change records after the first sale so the assessment remains usable.
Frequently asked questions
Are all Korean skincare products functional cosmetics?
No. Classification depends on the defined scope and the product’s purpose and presentation. Assess the complete claims and use rather than treating skincare as one regulatory category.
Does functional status mean the product is a medicine?
No. Functional cosmetics are a category within the Korean cosmetics framework. Claims implying disease treatment may raise separate classification concerns and require specific review.
Can every functional product use a report?
No. Verify the precise reporting criteria and product match. If the conditions do not support reporting, determine the applicable examination route and evidence requirements.
Can ingredient research prove the finished product’s claim?
It can inform the evidence assessment, but it is not automatically equivalent to evidence for the marketed formulation. Check the actual product, method and claim against the applicable requirements.
What happens if the formula changes after review?
Assess the difference before implementation. The change may affect the product route, existing record, test relevance, artwork or stock; retain the reviewer’s decision and supporting evidence.
Last reviewed: 27 October 2026. General planning information, not product-specific legal, regulatory or safety advice. Confirm the current Korean requirements and the intended commercial route with a qualified local adviser before importing or selling.